Laurion Capital Management’s Applied Therapeutics APLT Stock Holding History

Laurion Capital Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-50,000	Closed	-$42.8K	–	276
2024 Q4	$42.8K	Hold	50,000	–	–	﹤0.01%	278
2024 Q3	$425K	Hold	50,000	–	–	0.01%	211
2024 Q2	$234K	Sell	50,000 -1,431,006	-97%	-$6.77M	﹤0.01%	460
2024 Q1	$10.1M	Buy	1,481,006 +1,050,000	+244%	+$4.71M	0.09%	191
2023 Q4	$1.44M	Buy	431,006 +85,106	+25%	+$212K	0.01%	317
2023 Q3	$861K	Hold	345,900	–	–	0.01%	372
2023 Q2	$443K	Hold	345,900	–	–	﹤0.01%	430
2023 Q1	$281K	Hold	345,900	–	–	﹤0.01%	367
2022 Q4	$263K	Hold	345,900	–	–	﹤0.01%	377
2022 Q3	$322K	Hold	345,900	–	–	﹤0.01%	423
2022 Q2	$328K	Buy	+345,900	New	+$566K	0.01%	365
2020 Q2	–	Sell	-10,000	Closed	-$327K	–	903
2020 Q1	$327K	Buy	+10,000	New	+$404K	﹤0.01%	623

Other funds holding APLT

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Laurion Capital Management's APLT Position: Q1 2025 in Review

Laurion Capital Management sold out of Applied Therapeutics (APLT) in Q1 2025, closing a stake of 50,000 shares — an estimated $42.8K sold.

Laurion Capital Management first reported a position in APLT in Q1 2020 and held it in 12 quarters. The position peaked at $10.1M in Q1 2024. 89 funds tracked by Wall St. Rank hold APLT as of Q1 2025.

Laurion Capital Management reported no remaining Applied Therapeutics position as of Q1 2025 after selling out during the quarter.
Laurion Capital Management sold 50,000 Applied Therapeutics shares in Q1 2025, an estimated $42.8K.
Laurion Capital Management first reported a position in Applied Therapeutics in Q1 2020 and held it in 12 quarters.
Laurion Capital Management's Applied Therapeutics position peaked at $10.1M in Q1 2024.
89 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2025.

Based on Laurion Capital Management's 13F filing for Q1 2025, filed 15 May 2025.